Half-year report · Q2
4480.TEDINET S100U80N
Period2024-01-01 → 2024-06-30
Filed2024-08-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥14.7bn | 2024-01-01 → 2024-06-30 | Cons. | Net sales |
| Revenue | ¥20.5bn | 2023-01-01 → 2023-12-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥10.7bn | 2023-01-01 → 2023-06-30 | Cons. | Net sales |
| Operating income | ¥2.3bn | 2024-01-01 → 2024-06-30 | Cons. | Operating income |
| Operating income | ¥2.4bn | 2023-01-01 → 2023-06-30 | Cons. | Operating income |
| Ordinary income | ¥3.2bn | 2024-01-01 → 2024-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥3.8bn | 2023-01-01 → 2023-12-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.8bn | 2023-01-01 → 2023-06-30 | Cons. | Ordinary income |
| Profit before tax | ¥3.2bn | 2024-01-01 → 2024-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥2.8bn | 2023-01-01 → 2023-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥2.0bn | 2024-01-01 → 2024-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥2.6bn | 2023-01-01 → 2023-12-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.9bn | 2023-01-01 → 2023-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥2.1bn | 2024-01-01 → 2024-06-30 | Cons. | Profit loss |
| Net income | ¥1.9bn | 2023-01-01 → 2023-06-30 | Cons. | Profit loss |
| Total assets | ¥42.2bn | at 2024-06-30 | Cons. | Assets |
| Total assets | ¥25.4bn | at 2023-12-31 | Cons. | Assets |
| Total assets | ¥24.5bn | at 2023-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥22.6bn | at 2024-06-30 | Cons. | Liabilities |
| Total liabilities | ¥7.8bn | at 2023-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥19.5bn | at 2024-06-30 | Cons. | Net assets |
| Net assets / equity | ¥17.6bn | at 2023-12-31 | Cons. | Net assets |
| Net assets / equity | ¥17.2bn | at 2023-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥20.9bn | at 2024-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥15.4bn | at 2023-12-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥20.9bn | at 2024-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥15.4bn | at 2023-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥15.9bn | at 2023-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥14.4bn | at 2022-12-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥2.5bn | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥3.9bn | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥2.8bn | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥8.2bn | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥1.7bn | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥805m | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥11.1bn | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥1.2bn | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥385m | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥61.9 | 2024-01-01 → 2024-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥79.53 | 2023-01-01 → 2023-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥58.48 | 2023-01-01 → 2023-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥61.5 | 2024-01-01 → 2024-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥78.55 | 2023-01-01 → 2023-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥57.65 | 2023-01-01 → 2023-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 46.1% | at 2024-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 69.0% | at 2023-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 69.9% | at 2023-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 34
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2024-01-01 → 2024-06-30 | −¥2m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-01-01 → 2024-06-30 | −¥2m |
| Reconciling Itemsreconciling | segment profit | 2024-01-01 → 2024-06-30 | −¥2.2bn |
| jpcrp040300-q2r_E33586-000Medical Platform Businessreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥3.5bn |
| jpcrp040300-q2r_E33586-000Medical Platform Businessreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥3.5bn |
| jpcrp040300-q2r_E33586-000Medical Platform Businessreportable segment | segment profit | 2024-01-01 → 2024-06-30 | ¥30m |
| jpcrp040300-q2r_E33586-000New Business Development Servicesreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥331m |
| jpcrp040300-q2r_E33586-000New Business Development Servicesreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥331m |
| jpcrp040300-q2r_E33586-000New Business Development Servicesreportable segment | segment profit | 2024-01-01 → 2024-06-30 | −¥119m |
| jpcrp040300-q2r_E33586-000Recruitment Platform Businessreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥10.9bn |
| jpcrp040300-q2r_E33586-000Recruitment Platform Businessreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥10.9bn |
| jpcrp040300-q2r_E33586-000Recruitment Platform Businessreportable segment | revenue intersegment | 2024-01-01 → 2024-06-30 | ¥2m |
| jpcrp040300-q2r_E33586-000Recruitment Platform Businessreportable segment | segment profit | 2024-01-01 → 2024-06-30 | ¥4.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-01-01 → 2024-06-30 | ¥14.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-01-01 → 2024-06-30 | ¥14.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-01-01 → 2024-06-30 | ¥2m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-01-01 → 2024-06-30 | ¥4.5bn |
| Reconciling Itemsreconciling | revenue | 2023-01-01 → 2023-06-30 | −¥1m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-01-01 → 2023-06-30 | −¥1m |
| Reconciling Itemsreconciling | segment profit | 2023-01-01 → 2023-06-30 | −¥1.2bn |
| jpcrp040300-q2r_E33586-000Medical Platform Businessreportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥2.9bn |
| jpcrp040300-q2r_E33586-000Medical Platform Businessreportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥2.9bn |
| jpcrp040300-q2r_E33586-000Medical Platform Businessreportable segment | segment profit | 2023-01-01 → 2023-06-30 | −¥38m |
| jpcrp040300-q2r_E33586-000New Business Development Servicesreportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥178m |
| jpcrp040300-q2r_E33586-000New Business Development Servicesreportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥178m |
| jpcrp040300-q2r_E33586-000New Business Development Servicesreportable segment | segment profit | 2023-01-01 → 2023-06-30 | −¥121m |
| jpcrp040300-q2r_E33586-000Recruitment Platform Businessreportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥7.7bn |
| jpcrp040300-q2r_E33586-000Recruitment Platform Businessreportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥7.7bn |
| jpcrp040300-q2r_E33586-000Recruitment Platform Businessreportable segment | revenue intersegment | 2023-01-01 → 2023-06-30 | ¥1m |
| jpcrp040300-q2r_E33586-000Recruitment Platform Businessreportable segment | segment profit | 2023-01-01 → 2023-06-30 | ¥3.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-01-01 → 2023-06-30 | ¥10.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-01-01 → 2023-06-30 | ¥10.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-01-01 → 2023-06-30 | ¥1m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-01-01 → 2023-06-30 | ¥3.6bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 526
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)EY新日本有限責任監査法人 | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)池 内 基 明 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)小 山 浩 平 | |
| Cpa3 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)鴇 田 直 樹 | |
| Number of submission | FilingDateInstant | 1 | |
| Net sales (5-year summary) | Prior1YTDDuration | 10707000000 | JPY |
| Net sales (5-year summary) | CurrentYTDDuration | 14706000000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration | 20532000000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YTDDuration | 2781000000 | JPY |
| Ordinary income loss (5-year summary) | CurrentYTDDuration | 3167000000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration | 3755000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YTDDuration | 1884000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | CurrentYTDDuration | 2008000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YearDuration | 2566000000 | JPY |
| Comprehensive income (5-year summary) | Prior1YTDDuration | 1921000000 | JPY |
| Comprehensive income (5-year summary) | CurrentYTDDuration | 2083000000 | JPY |
| Comprehensive income (5-year summary) | Prior1YearDuration | 2287000000 | JPY |
| Net assets (5-year summary) | Prior1QuarterInstant | 17231000000 | JPY |
| Net assets (5-year summary) | CurrentQuarterInstant | 19534000000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant | 17637000000 | JPY |
| Total assets (5-year summary) | Prior1QuarterInstant | 24501000000 | JPY |
| Total assets (5-year summary) | CurrentQuarterInstant | 42165000000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant | 25430000000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1YTDDuration | 58.48 | |
| Basic earnings loss per share (5-year summary) | CurrentYTDDuration | 61.90 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | 79.53 | |
| Diluted earnings per share (5-year summary) | Prior1YTDDuration | 57.65 | |
| Diluted earnings per share (5-year summary) | CurrentYTDDuration | 61.50 | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | 78.55 | |
| Equity to asset ratio (5-year summary) | Prior1QuarterInstant | 0.699 | |
| Equity to asset ratio (5-year summary) | CurrentQuarterInstant | 0.461 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.690 | |
| Net cash provided by used in operating activities (5-year summary) | Prior1YTDDuration | 2758000000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | CurrentYTDDuration | 2510000000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior1YearDuration | 3871000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YTDDuration | -805000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | CurrentYTDDuration | -8155000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YearDuration | -1662000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YTDDuration | -385000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | CurrentYTDDuration | 11126000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YearDuration | -1218000000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1QuarterInstant | 15928000000 | JPY |
| Cash and cash equivalents (5-year summary) | CurrentQuarterInstant | 20852000000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1YearInstant | 15351000000 | JPY |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 32738600 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 32738600 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 32738600 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 32738600 | |
| Number of shares held | CurrentQuarterInstant_No1MajorShareholdersMember | 5989000 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |